• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
EndeavorRx screen (Akili Interactive)
June 16, 2020 09:26 AM EDTUpdated 12:20 PM
FDA+

FDA ap­proves first ther­a­peu­tic video game

Jason Mast

Editor

Here’s a new one: The FDA has just ap­proved a pre­scrip­tion video game.

The brain­child of a cou­ple of cog­ni­tive sci­en­tists who built the pro­to­type …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

more like this

  • White House of­fi­cials link phar­ma tar­iffs with ‘most fa­vored na­tion’ pric­ing pro­gram August 26, 2025
  • Lil­ly will seek ap­proval of GLP-1 pill af­ter suc­cess­es in pa­tients with both obe­si­ty and di­a­betes August 26, 2025
  • HHS winds down pe­di­atric brain tu­mor pact af­ter 26 years, pri­or­i­tiz­ing oth­er child­hood can­cer work August 25, 2025
TRENDING NOW

Amy­lyx's old ALS drug fails in an­oth­er neu­ro dis­ease, fo­cus turns to GLP-1

New re­search foun­da­tion com­mits $500M to fund­ing 'long bet­s' in sci­ence

FDA ap­proves up­dat­ed Covid vac­cines, in­clud­ing mR­NA shots from Pfiz­er, Mod­er­na

FDA talks lim­i­ta­tions, po­ten­tial for can­cer reg­istries

Prasad's re­turn to FDA comes with few­er ti­tles and a seem­ing­ly low­er pro­file

Wu­gen col­lects $115M as it runs piv­otal al­lo­gene­ic CAR-T tri­al

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times